bibliographicCitation |
Junquero D, Pilon A, Carilla-Durand E, Patoiseau J, Tarayre J, Torpier G, Staels B, Fruchart J, Colpaert FC, Clavey V, Delhon A. Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture11Abbreviations: ACAT, acyl-coenzyme A: cholesterol O-acyltransferase; F 12511, (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthio-phenylacetanilide; DMEM, Dulbecco’s modified Eagle medium; FBS, fetal bovine serum; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SR-BI, scavenger receptor class B, type I; P450scc, cytochrome P450 cholesterol side-chain cleavage; P450c17, cytochrome P450 17 α-hydroxylase; P450c21, cytochrome P450 21-hydroxylase; PMA, phorbol 12-myristate 13-acetate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; cAMP, adenosine 3′5′-cyclic monophosphate; ITS, insulin-transferrin-linoleic acid; and MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. Biochemical Pharmacology. 2001 Feb;61(4):387–98. doi: 10.1016/s0006-2952(00)00555-4. |
title |
Lack of toxic effects of F 12511, a novel potent inhibitor of acyl-coenzyme A: cholesterol O-acyltransferase, on human adrenocortical cells in culture11Abbreviations: ACAT, acyl-coenzyme A: cholesterol O-acyltransferase; F 12511, (S)-2′,3′,5′-trimethyl-4′-hydroxy-α-dodecylthio-phenylacetanilide; DMEM, Dulbecco’s modified Eagle medium; FBS, fetal bovine serum; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SR-BI, scavenger receptor class B, type I; P450scc, cytochrome P450 cholesterol side-chain cleavage; P450c17, cytochrome P450 17 α-hydroxylase; P450c21, cytochrome P450 21-hydroxylase; PMA, phorbol 12-myristate 13-acetate; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; cAMP, adenosine 3′5′-cyclic monophosphate; ITS, insulin-transferrin-linoleic acid; and MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide. |